<DOC>
	<DOCNO>NCT00820196</DOCNO>
	<brief_summary>Venous leg ulcer common , costly debilitate condition , effective treatment . Compression bandage help heal , four every ten leg ulcer remain unhealed three month . New treatment help heal venous ulcer urgently need . Initial study new drug product candidate call Nexagon® ( develop CoDa Therapeutics , Inc. ) show improvement heal apply topically wind . Further research undertaken assess safety activity Nexagon® apply venous leg ulcer human , obtain information appropriate dose dose apply . A propose randomise control trial aim evaluate Nexagon® randomly allocate ( e.g. , toss coin ) 90 people venous leg ulcer Nexagon® ( one two different dos ) vehicle ( substance contain medication ) apply ulcer three time four week . Participants follow 12 week evaluate ulcer healing .</brief_summary>
	<brief_title>A Trial Assess Safety Activity Nexagon® Treatment Venous Leg Ulcers ( The NOVEL Study )</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>1 . Diagnosis venous leg ulceration 2 . Ankle brachial index &gt; 0.80 measure screening within three month prior Day 14 visit . 3 . Reference ulcer area great 1 cm2 less 25 cm2 4 . Reference ulcer present least 4 week 5 . Have ankle circumference great 18 cm 6 . Male female patient age 18 year 7 . Able tolerate effective compression bandage 8 . Patients able walk independently without mobility aid 9 . Able willing give inform consent 10 . Able willing attend follow visit 1 . Significant change ulcer size screen period screen period 2 . Presence nonstudy ulcer within 2.0 cm reference ulcer 3 . Wound bed expose bone , tendon fascia 4 . Patients leg ulceration etiology venous insufficiency 5 . Patients require wheel chair normal mobility 6 . Patients ulcer ( reference nonreference ) show sign clinical infection 7 . Patients ulcer ( reference nonreference ) positive βhemolytic streptococcus upon culture . 8 . Patients unable tolerate comply standardize compression bandage protocol specify protocol 9 . Female patient pregnant breastfeeding . 10 . Patients currently take : 1 . Pentoxifylline ( Trental® ) 2 . Immunosuppressive therapy 3 . Oral corticosteroid therapy topical corticosteroid leg reference ulcer locate 4 . Growth factor ( e.g . Regranex ) 5 . Cell culture topical skin factor 11 . Patients : 1 . Renal insufficiency define estimate GFR &lt; 30 mL/min/1.7m2 2 . Abnormal blood biochemistry define 3 time upper limit normal range 3 . Hepatic insufficiency define total bilirubin &gt; 2 mg/dL serum albumin &lt; 25 g/L 4 . HbA1c &gt; 8.5 % 5 . Hemoglobin &lt; 10 g/dL 6 . Hematocrit &lt; 0.30 7 . Platelet count &lt; 100,000 12 . Patients myocardial infarction within previous 6 month patient unstable angina pectoris 13 . Patients : 1 . Collagen vascular disease 2 . Severe rheumatoid arthritis 3 . Cellulitis osteomyelitis 14 . Patients , suspected malignancy , receive treatment active malignancy , apart nonmelanomatic skin cancer , within 3 month prior treatment 15 . Patients , opinion Investigator , exist condition would compromise participation followup study , e.g. , know abuse alcohol drug currently psychological disorder could affect followup care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Venous ulcer</keyword>
	<keyword>Nexagon</keyword>
	<keyword>CoDa</keyword>
</DOC>